Environmental Health Institute report concludes evidence is 'weak' that electric and magnetic fields cause cancer

June 15, 1999

After six years of accelerated, Congressionally mandated research, the National Institute of Environmental Health Sciences today announced it has concluded that the evidence for a risk of cancer and other human disease from the electric and magnetic fields (EMF) around power lines is "weak."

NIEHS' review and analysis of the existing data came in a report to Congress, released today. The report applies to the extremely low frequency electric and magnetic fields surrounding both the big power lines that distribute power and the smaller but closer electric lines in homes and appliances.

While sections of the report say EMF exposure "cannot be recognized as entirely safe," the report concludes: "The NIEHS believes that the probability that EMF exposure is truly a health hazard is currently small. The weak epidemiological associations and lack of any laboratory support for these associations provide only marginal scientific support that exposure to this agent is causing any degree of harm."

Research continues on some "lingering concerns," the report says, and efforts to reduce exposures should continue.

NIEHS said that the "strongest evidence" for health effects comes from statistical associations observed in human populations with childhood leukemia and chronic lymphocytic leukemia in occupationally exposed adults such as electric utility workers, machinists and welders. "While the support from individual studies is weak," according to the report, "these epidemiological studies demonstrate, for some methods of measuring exposure, a fairly consistent pattern of a small, increased risk with increasing exposure that is somewhat weaker for chronic lymphocytic leukemia than for childhood leukemia."

However, laboratory studies and investigations of basic biological function do not support these epidemiological associations, according to the report. It says, "Virtually all of the laboratory evidence in animals and humans and most of the mechanistic studies in cells fail to support a causal [cause and effect] relationship."

NIEHS Director Kenneth Olden, Ph.D., said, "The lack of consistent, positive findings in animal or mechanistic studies weakens the belief that this association is actually due to EMF, but it cannot completely discount the epidemiological findings. For that reason, and because virtually everyone in the United States uses electricity and therefore is routinely exposed to EMF, efforts to encourage reductions in exposure should continue. For example, industry should continue efforts to alter large transmission lines to reduce their fields and localities should enforce electrical codes to avoid wiring errors that can produce higher fields." An interagency committee established by the President will make a subsequent report to Congress about the findings of this report and whether any remedial actions are needed to minimize exposures.

Dr. Olden said NIEHS would continue to support some research on EMF, though not at the high levels Congress provided in special legislation and appropriations.

The NIEHS report follows a six-year research program and a two-year review by the institute and by outside scientists. For the effort, Congress appropriated $23 million that the electrical industry matched. The industry had no control over what research was conducted. The funds were administered by the Department of Energy and a portion was transferred to NIEHS, targeted for health effects research. NIEHS also added $14 million of its own appropriated funds to support additional research. The total expenditure was about $60 million.

The studies reviewed and conducted by NIEHS and its grantees focused on the possibility of a link to cancer ? a reaction to a leukemia study in Denver, Colo., in 1979, and to subsequent attempts to duplicate or refute it in Denver and elsewhere. But the report said NIEHS also found inadequate evidence of any link to such non-cancer diseases as Alzheimer's, depression and birth defects. Christopher Portier, Ph.D., the associate director of the Environmental Toxicology Program at NIEHS who coordinated the evaluation effort, said, "This risk assessment gains strength and reliability from the conduct of extensive new research focused to support the evaluation and through obtaining the opinion of hundreds of scientists who participated in the evaluation. The novel methods used in this risk assessment can serve as a blueprint for resolving other difficult issues."

To assist NIEHS in reaching its conclusions, several panels of scientists reviewed the data in open, public hearings. A major panel of scientists ? many of them EMF researchers ? was assembled in a suburb of Minneapolis, Minn., last June to advise NIEHS. The panel rejected EMF as a "known" or proven, or even "probable" carcinogen but a majority of the panel said a role in cancer could not be ruled out and so it should be regarded as "possible" carcinogen. The NIEHS report today also recommends that the fields continue to be recognized as a "possible" cancer hazard, but emphasizes the weakness of the data and the low risk that may be involved. The NIEHS report says the evidence does not seem to meet the standard for listing as a known or even "anticipated" human carcinogen in the National Toxicology Program's Report on Carcinogens.
-end-
NIEHS is one of the National Institutes of Health. NIEHS' headquarters and laboratories in Research Triangle Park, N.C., are also the headquarters of the National Toxicology Program, and they have the same director.

The report may be found on the Internet via www.niehs.nih.gov/emfrapid/ at noon EDT June 15, 1999. Printed copies of the report can be ordered by calling 919-541-7534, or e-mailing emf-rapid@niehs.nih.gov. To order by fax: 919-541-0144. Or write EMF-RAPID Program, NIEHS PO Box 12233, Mail drop EC-16, Research Triangle Park, NC 27709.



NIH/National Institute of Environmental Health Sciences

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.